optomap imaging can assist eyecare professional to find and document AMD earlier and potentially change the course of the disease.
February is additionally observed as Low Vision Awareness Month. During this time, we all have the opportunity to raise awareness about visual impairment and rehabilitation for those who are living with low vision.
Findings suggest that optomap fa imaging may improve clinician’s ability to identify signs of diabetic retinopathy progression.
Glaucoma is a group of eye diseases that progress gradually, stealing sight, without showing symptoms. The word ‘glaucoma’ is actually an umbrella term for a group of eye diseases that damage the delicate fibers that run from your eye to your optic nerve, which is the nerve that carries information about the images your eye sees to your brain. Damage is often the result of high fluid pressure inside the eye. Glaucoma can affect people of all ages but is most prevalent in middle-aged adults and the elderly. While there is no cure, surgery or medication can slow its effects and help to prevent further vision loss.
Results of a recent study shows excellent agreement in the assessment of the peripheral retina and suggest that optomap imaging is a useful tool in the assessment of eyes with peripheral retinal lesions, with a high sensitivity and reproducibility.